Multi-omic biomarker discovery and network analyses to elucidate the molecular mechanisms of lung cancer premalignancy
Lung cancer (LC) is the leading cause of cancer death in the US, claiming over 160,000 lives annually. Although CT screening has been shown to be efficacious in reducing mortality, the limited access to screening programs among high-risk individuals and the high number of false positives contribute...
| Main Author: | |
|---|---|
| Language: | en_US |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/27344 |